Drugs / Rotigotine Nasal Spray
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00389831 | Aug → Nov 2006 | restless legs syndrome | UCB Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotigotine Nasal Spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00389831 ↗ |
| Route | Intranasal | “rotigotine delivered as single puff of nasal spray solution” NCT00389831 ↗ |